Levokast Kid Tablet is a combination medication containing Levocetirizine 2.5 mg and Montelukast 4 mg, formulated specifically for pediatric use to manage allergic conditions. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby alleviating symptoms such as sneezing, rhinorrhea, nasal congestion, and itching associated with allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, blocks cysteinyl leukotriene receptors, reducing inflammation, bronchoconstriction, and mucus production, which are key contributors to asthma and allergic rhinitis pathophysiology. The synergistic effect of these two agents provides comprehensive relief from allergic symptoms and improves respiratory function in children. Levokast Kid Tablet is indicated for the treatment of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as adjunctive therapy in pediatric asthma management. The combination is generally well-tolerated, with a low incidence of adverse effects such as headache, fatigue, or gastrointestinal discomfort. It is recommended to administer the tablet once daily, preferably in the evening, under medical supervision. Caution is advised in patients with hepatic or renal impairment. Levokast Kid Tablet offers an effective and convenient therapeutic option for pediatric patients suffering from allergic disorders.